28 results on '"Pinpathomrat, Nawamin"'
Search Results
2. Immunogenicity of a fractional or full third dose of AZD1222 vaccine or BNT162b2 messenger RNA vaccine after two doses of CoronaVac vaccines against the Delta and Omicron variants
3. Impaired neutralizing antibodies and preserved cellular immunogenicity against SARS-CoV-2 in systemic autoimmune rheumatic diseases
4. Author Correction: Immunogenicity and safety of an intradermal ChAdOx1 nCoV-19 boost in a healthy population
5. Immunogenicity and safety of an intradermal ChAdOx1 nCoV-19 boost in a healthy population
6. Evaluation of the immunogenicity of a promising vaccine regimen to identify immune correlates of protection
7. Intradermal Fractional ChAdOx1 nCoV-19 Booster Vaccine Induces Memory T Cells: A Follow-Up Study
8. Unveiling Post-COVID-19 Syndrome: Incidence, Biomarkers, and Clinical Phenotype in a Thai Population
9. Effectiveness of plant-based hand sanitizer incorporating Quercus infectoria gall extract
10. A five-antigen Esx-5a fusion delivered as a prime-boost regimen protects against M.tb challenge
11. Heterologous COVID-19 Vaccination and Booster with mRNA Vaccine Provide Enhanced Immune Response in Patients with Cirrhosis: A Prospective Observational Study
12. Identification of antigens presented by MHC for vaccines against tuberculosis
13. Humoral Immunogenicity of mRNA Booster Vaccination after Heterologous CoronaVac-ChAdOx1 nCoV-19 or Homologous ChAdOx1 nCoV-19 Vaccination in Patients with Autoimmune Rheumatic Diseases: A Preliminary Report
14. Characteristics, Outcomes, and Factors Affecting Mortality in Hospitalized Patients with CAP Due to Different Variants of SARS-CoV-2 and Non-COVID-19 CAP
15. Immunogenicity of a fractional or full third dose of AZD1222 vaccine or BNT162b2 mRNA vaccine after two doses of CoronaVac vaccines against Delta and Omicron variants
16. T-Cell Responses Induced by an Intradermal BNT162b2 mRNA Vaccine Booster Following Primary Vaccination with Inactivated SARS-CoV-2 Vaccine
17. Regulatory T Cells Decreased during Recovery from Mild COVID-19
18. Heterologous SARS-CoV-2 vaccine triggers more humoral immune responses among patients with liver cirrhosis
19. Regulatory T cells decreased during recovery from mild COVID-19 infection
20. Coronavirus Disease 2019 Vaccinations in Patients With Chronic Liver Disease and Liver Transplant Recipients: An Update
21. Impaired Neutralising Antibodies to SARS-CoV-2 Omicron BA.2 Variant and Preserved Cellular Immunogenicity Following Heterologous Prime-Boost Vaccination with an Inactivated Vaccine Followed by ChAdOx1-nCoV-19 in Patients with Systemic Autoimmune Rheumatic Diseases
22. Immunogenicity and Safety of an Intradermal BNT162b2 mRNA Vaccine Booster after Two Doses of Inactivated SARS-CoV-2 Vaccine in Healthy Population
23. Using an effective TB vaccination regimen to identify immune responses associated with protection in the murine model
24. Assessment of the reproducibility and inter-site transferability of the murine direct splenocyte mycobacterial growth inhibition assay (MGIA)
25. MAVS Deficiency Is Associated With a Reduced T Cell Response Upon Secondary RSV Infection in Mice
26. Identification and Evaluation of Novel Protective Antigens for the Development of a Candidate Tuberculosis Subunit Vaccine
27. Hepcidin deficiency and iron deficiency do not alter tuberculosis susceptibility in a murine M.tb infection model
28. Humoral SARS-CoV-2 immunogenicity wanes 3 months after heterologous inactivated vaccine followed by ChAdOx1 nCoV-19 in autoimmune rheumatic diseases.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.